Virbac has reported sales of €225.5 million ($301.1 million) for the first half of 2009, an increase of 6.4% over the previous year. Organic growth in sales of companion animal products (+3.5%) benefited from the launch of new products in Europe, notably the canine ear treatment Easotic and ...
Animal Pharm
New products and acquisitions boost Virbac H1
01 September 2009
Nathalie Caplet
Not a subscriber ? Request a FREE Trial
Subscribe to Animal Pharm
NEWS
Animal Pharm News
Other News
FEATURES & ANALYSIS
Animal Pharm Features &
Analysis
Other Features & Analysis
EVENTS
Today
Olsztyn, Poland
13 September 2010
Vlieland, the Netherlands
14 September 2010
Brussels, Belgium
